Aperiam Bio
PrivateLast Round
Seed
Nov 29, 2023
Total Funding Raised
$9M
Company Overview
Aperiam Bio is a biotechnology company that applies a patented, 3D computer vision algorithm to identify improvements to proteins, making them more effective and durable for industrial and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Computer Vision, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aperiam Bio Comparables
Compare Aperiam Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pando Bioscience | 83% | |
| Amineo | 81% | |
| Cambrium | 81% |
Aperiam Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 29, 2023 |
Aperiam Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OMX Ventures | Seed |
| Axial VC | Seed |
| Civilization Ventures | Seed |
| KdT Ventures | Seed |
| Axial VC | Seed |
Aperiam Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aperiam Bio's valuation, stock price, and market status.
Is Aperiam Bio a public or private company?
Aperiam Bio is a private company.
What is the current stock price of Aperiam Bio?
Aperiam Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Aperiam Bio worth (valuation)?
Valuation information for Aperiam Bio is not publicly available.
Can I buy Aperiam Bio stock?
Aperiam Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aperiam Bio's last funding round?
Aperiam Bio's most recent funding round was Seed on November 29, 2023.
Who are the main investors in Aperiam Bio?
Key investors in Aperiam Bio include OMX Ventures.
Will Aperiam Bio IPO soon?
No public IPO plans have been announced for Aperiam Bio.
How can I track Aperiam Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aperiam Bio's secondary market activity and sign up for updates.